Newsletter | September 21, 2022

09.21.22 -- 3 Strategies For Diverse, Large-Scale Clinical Studies

Featured Editorial
Industry Insights
How To Improve Recruitment Rates, Reduce Site Burden, And Avoid Wasted Spending

Explore why the Facebook ban on ads that target patients is an opportunity to push clinical research to accelerate more patient-centric advertising models that enable privacy.

Benefits Of Leveraging Real-World Data (RWD) To Conduct Long-Term Follow Up

In this webinar, panelists will discuss how this approach enables many benefits, including the ability to supplement data for patients lost to follow up and augment trial data to help explain non-responders and adverse events.

6 Data Linkage Use Cases To Future-Proof Your Clinical Trial

Learn how connecting clinical trial data and real-world data can gain a fuller view of the patient journey and enhance evidence generation.

Modern Decentralized Trials Demand Advanced eClinical Support

First-generation eClinical systems can create as many challenges as they resolve. A more coherent solution is necessary to ensure data integrity, ease site burdens, and promote greater patient centricity.

The Largest Parkinson’s Disease Study Ever Attempted Is Being Made Possible Only With Mobile Research Nurses

The trial of Parkinson’s and zoledronic acid (TOPAZ) is seeking to enroll 3,500 participants over the age of 60, making it the largest double-blind, placebo-controlled, randomized clinical trial ever attempted in people with Parkinsonism. Find out the approaches taken and the results in this case study.

Humans And Artificial Intelligence Unite

Medical information organizations are redefining how people and AI can work together to rapidly respond to the surge in customer requests.

How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers

Discover why engaging randomization and trial supply management (RTSM) services early in study start-up can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.

Featured Editorial
Industry Insights
Importance Of Seeking Patient Insights To Develop Effective Decentralized Clinical Trial Strategies

The industry is aware that deep insights are required to develop patient-focused protocols, trial designs, enrollment, retention strategies, and shared decision-making tools. Discover the questions that need to be asked in order to reach these goals.

How To Prepare An IRB Submission For A Remote eConsent Study

IRBs are increasingly supportive of eConsent solutions. Even so, researchers may find themselves in need of guidance as they prepare for an eConsent IRB review.

Risks To Sponsors Developing And Running Their Own DCT Technology

 Delve into the considerations of inadequate data in DCTs and how a sponsor can ensure it exerts appropriate control over the DCT technologies in place.

Enhancing Research Conduct Using eConsent

This blog defines eConsent, offers considerations for conducting eConsent, and navigates communicating with your institutional review board (IRB) as you figure out how to include this process at your organization.

Clinical Trial Modernization: Optimizing The Supply Of Decentralized Studies

Clinical sites and sponsors have had to quickly implement solutions, and biopharma companies are heeding the call to innovate, be agile, reduce waste, and, most of all, achieve patient centricity.

Tips For Overcoming Today's Drug Supply Challenges Through Technology

In this webinar, explore how to manage a supply chain through IRT with self-service tools and actionable insights as well as best practices for supply forecasting and overstock management.

The 3 Cs You Should Expect From Your Pharma Service Provider

When asked about the biggest challenges to the pharmaceutical company sponsor-contract service provider relationship, sponsors and service providers offer pretty consistent responses.  

New Podcast Episode
Industry Insights
What Does “Good” Look Like In A Decentralized Clinical Trial?

This article seeks to answer the question: What is the right way to perform decentralized trials in order that they can be controlled and managed effectively?

Three Ways That eCOA Improves Data Quality

Follow a quick guide to the key ways that eCOA works to help all study stakeholders (patients, caregivers, study teams, etc.) produce better data.

Three Considerations For A Successful Global Sample Processing With A Central Laboratory

Sample preparation and processing are crucial steps in immuno-oncology, diagnostics, and cell and gene therapies. Obtaining timely, high-quality preparation and processing services on a global basis is a universal challenge. This webinar considers three keys to a successful global sample processing: specimen collection and transport, consistency in analytical technique, and biostorage.

Decentralized Clinical Trials: A Win For Patients, Sponsors, And Investigators

Learn how the integral role of direct-to-patient services plays a part in the execution of decentralized trials and how sponsors can maximize these benefits to improve drug development.

Leveraging Clinical Trial Data In Real Time To Effect Change And Mitigate Risk

Learn how clinical trial data gathering, contextualization, and analysis can all benefit from existing — but underutilized — technologies and resources.

eTMF Implementation Quick Guide

Implementing an eTMF for the first time can feel like a daunting process. This checklist will help you focus on some primary considerations to reduce risks, maintain compliance, and establish effective processes in your eTMF so that your team embodies a culture of inspection readiness from the start.

Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.